Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.760
+0.030 (1.73%)
Sep 2, 2025, 10:30 AM - Market open

Neumora Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Neumora Therapeutics stock have a consensus rating of "Buy" and an average price target of $7.14, which forecasts a 305.68% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $18.

Price Target: $7.14 (+305.68%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$1.00$7.14$5.00$18
Change-43.18%+305.68%+184.09%+922.73%
* Price targets were last updated on Jul 16, 2025.

Analyst Ratings

The average analyst rating for Neumora Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy322222
Buy111111
Hold444444
Sell011111
Strong Sell000000
Total888888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Mizuho
Mizuho
Buy
Maintains
$4$5
BuyMaintains$4$5+184.09%Jul 16, 2025
Needham
Needham
Strong Buy
Reiterates
$5
Strong BuyReiterates$5+184.09%May 13, 2025
Needham
Needham
Strong Buy
Reiterates
$5
Strong BuyReiterates$5+184.09%Apr 10, 2025
B of A Securities
B of A Securities
Sell
Downgrades
$7$1
SellDowngrades$7$1-43.18%Apr 2, 2025
Guggenheim
Guggenheim
Hold
Downgrades
n/a
HoldDowngradesn/an/aMar 10, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
4.25M
EPS This Year
-1.44
from -1.53
EPS Next Year
-1.09
from -1.44
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------4.25M
Revenue Growth
-------
EPS
-7.64-10.84-4.81-3.63-1.53-1.44-1.09
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1010
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/a26.3M
Avgn/a4.3M
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-1.39-0.61
Avg-1.44-1.09
Low-1.51-1.59

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.